Stock data
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM) reported revenue of US$521.31M and net income of -US$23.36M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$521.31M | — | -US$22.14M | -US$23.36M | — |
| 2024 | US$336.89M | — | -US$87.61M | -US$87.94M | — |
| 2023 | US$186.37M | — | -US$109.15M | -US$163.41M | — |
| 2022 | US$77.06M | — | -US$131.22M | -US$135.66M | — |
| 2021 | US$19.14M | — | -US$173.41M | -US$83.99M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$176.24M | -US$67.23M | — |
| 2026-03-31 | US$159.88M | -US$790.15M | — |
| 2025-12-31 | US$148.93M | -US$5.73M | — |
| 2025-09-30 | US$133.01M | US$2.90M | — |
| 2025-06-30 | US$127.78M | -US$5.86M | — |
| 2025-03-31 | US$111.58M | -US$14.68M | — |
| 2024-12-31 | US$99.41M | -US$23.79M | — |
| 2024-09-30 | US$90.38M | -US$14.23M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.